Bristol-Myers Squibb Could Finally Go on the Market; Rumored Suitors Include Gilead, Pfizer, Novartis AG and Roche Post author:Sam Post published:February 13, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Deal Spree Continues as Allergan Inks $2.47 Billion Deal for This Bay Area Biotech February 12, 2017 Ophthotech's Wet AMD Drug Fails to Meet Primary Endpoint in Phase III Study August 13, 2017 Almirall Discontinues R&D for Two Drugs in the U.S. September 28, 2017